Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A slow-growing malignant bone tumor arising from the remnants of the notochord and occurring in the clivus. It is characterized by a lobulated growth pattern, myxoid stroma formation, and the presence of physaliphorous cells.
Biomarker and diagnostic research for clivus chordoma has been reported in the published literature.
No clinical trials have been registered for clivus chordoma.
13 publications have been identified in PubMed for clivus chordoma. Research spans Case Report / Case Series (69%), Other (8%), and Diagnostic / Biomarker (8%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 9 | 69% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 12:50 AM UTC
Common questions about clivus chordoma
1 |
8% |
Testing and diagnosis research | 1 | 8% |
Laboratory research | 1 | 8% |
Disease patterns and progression | 1 | 8% |
Morin L (2026). [PMID: 40359010](https://pubmed.ncbi.nlm.nih.gov/40359010/). *Clinical nuclear medicine*. [Basic Science / Preclinical]
Di Giorgio D (2025). [PMID: 38546282](https://pubmed.ncbi.nlm.nih.gov/38546282/). *British journal of neurosurgery*. [Diagnostic / Biomarker]
Bayar I (2025). [PMID: 40073404](https://pubmed.ncbi.nlm.nih.gov/40073404/). *Endocrine regulations*. [Case Report / Case Series]
Alshammari D (2025). [PMID: 39889656](https://pubmed.ncbi.nlm.nih.gov/39889656/). *International journal of surgery case reports*. [Case Report / Case Series]
Kopp S (2025). [PMID: 40773025](https://pubmed.ncbi.nlm.nih.gov/40773025/). *The international journal of cardiovascular imaging*. [Case Report / Case Series]
Eroglu U (2025). [PMID: 41212975](https://pubmed.ncbi.nlm.nih.gov/41212975/). *Operative neurosurgery (Hagerstown, Md.)*. [Case Report / Case Series]
Yasuda ME (2025). [PMID: 40972871](https://pubmed.ncbi.nlm.nih.gov/40972871/). *Journal of neurological surgery. Part A, Central European neurosurgery*. [Epidemiology / Natural History]
Alcântara T (2025). [PMID: 40206762](https://pubmed.ncbi.nlm.nih.gov/40206762/). *Surgical neurology international*. [Case Report / Case Series]
Grutza M (2024). [PMID: 39687083](https://pubmed.ncbi.nlm.nih.gov/39687083/). *Brain & spine*. [Other]
Uchimura M (2024). [PMID: 38966338](https://pubmed.ncbi.nlm.nih.gov/38966338/). *NMC case report journal*. [Case Report / Case Series]
AI-curated news mentioning clivus chordoma
Updated Jul 31, 2026
A recent study compares various fractionation schemes in carbon ion radiation therapy for sacrococcygeal chordomas. This research could inform treatment protocols and improve patient outcomes for this rare tumor type.
A new study presents a chemoresistance test aimed at predicting personalized therapeutic responses in pediatric patients with clivus chordoma. This research could enhance treatment strategies for this rare tumor type.